174 related articles for article (PubMed ID: 34369053)
1. Incorporating covariates information in adaptive clinical trials for precision medicine.
Zhao W; Ma W; Wang F; Hu F
Pharm Stat; 2022 Jan; 21(1):176-195. PubMed ID: 34369053
[TBL] [Abstract][Full Text] [Related]
2. A Unified Family of Covariate-Adjusted Response-Adaptive Designs Based on Efficiency and Ethics.
Hu J; Zhu H; Hu F
J Am Stat Assoc; 2015 Apr; 110(509):357-367. PubMed ID: 26120220
[TBL] [Abstract][Full Text] [Related]
3. Covariate-adjusted response-adaptive designs based on semiparametric approaches.
Zhu H; Zhu H
Biometrics; 2023 Dec; 79(4):2895-2906. PubMed ID: 36869863
[TBL] [Abstract][Full Text] [Related]
4. Relative efficiency of precision medicine designs for clinical trials with predictive biomarkers.
Shih WJ; Lin Y
Stat Med; 2018 Feb; 37(5):687-709. PubMed ID: 29205435
[TBL] [Abstract][Full Text] [Related]
5. Testing hypotheses under adaptive randomization with continuous covariates in clinical trials.
Li X; Zhou J; Hu F
Stat Methods Med Res; 2019 Jun; 28(6):1609-1621. PubMed ID: 29770730
[TBL] [Abstract][Full Text] [Related]
6. Maximum likelihood estimation of generalized linear models for adaptive designs: Applications and asymptotics.
Selvaratnam S; Yi Y; Oyet A
Biom J; 2019 May; 61(3):630-651. PubMed ID: 30536413
[TBL] [Abstract][Full Text] [Related]
7. Trial designs for personalizing cancer care: a systematic review and classification.
Tajik P; Zwinderman AH; Mol BW; Bossuyt PM
Clin Cancer Res; 2013 Sep; 19(17):4578-88. PubMed ID: 23788580
[TBL] [Abstract][Full Text] [Related]
8. Bayesian adaptive randomization designs for targeted agent development.
Lee JJ; Xuemin Gu ; Suyu Liu
Clin Trials; 2010 Oct; 7(5):584-96. PubMed ID: 20571130
[TBL] [Abstract][Full Text] [Related]
9. Bayesian adaptive design of early-phase clinical trials for precision medicine based on cancer biomarkers.
Yada S
Int J Biostat; 2021 Jun; 18(1):109-125. PubMed ID: 34114385
[TBL] [Abstract][Full Text] [Related]
10. Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review.
Ondra T; Dmitrienko A; Friede T; Graf A; Miller F; Stallard N; Posch M
J Biopharm Stat; 2016; 26(1):99-119. PubMed ID: 26378339
[TBL] [Abstract][Full Text] [Related]
11. Study designs and statistical analyses for biomarker research.
Gosho M; Nagashima K; Sato Y
Sensors (Basel); 2012; 12(7):8966-86. PubMed ID: 23012528
[TBL] [Abstract][Full Text] [Related]
12. Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.
Antoniou M; Jorgensen AL; Kolamunnage-Dona R
PLoS One; 2016; 11(2):e0149803. PubMed ID: 26910238
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial designs for testing biomarker-based personalized therapies.
Lai TL; Lavori PW; Shih MC; Sikic BI
Clin Trials; 2012 Apr; 9(2):141-54. PubMed ID: 22397801
[TBL] [Abstract][Full Text] [Related]
14. Optimal Bayesian adaptive trials when treatment efficacy depends on biomarkers.
Zhang Y; Trippa L; Parmigiani G
Biometrics; 2016 Jun; 72(2):414-21. PubMed ID: 26575199
[TBL] [Abstract][Full Text] [Related]
15. The benefits of covariate adjustment for adaptive multi-arm designs.
Lee KM; Robertson DS; Jaki T; Emsley R
Stat Methods Med Res; 2022 Nov; 31(11):2104-2121. PubMed ID: 35876412
[TBL] [Abstract][Full Text] [Related]
16. Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies.
Lin JA; He P
Br Med Bull; 2015 Jun; 114(1):17-27. PubMed ID: 25921239
[TBL] [Abstract][Full Text] [Related]
17. On study designs and hypotheses for clinical trials with predictive biomarkers.
Shih WJ; Lin Y
Contemp Clin Trials; 2017 Nov; 62():140-145. PubMed ID: 28838813
[TBL] [Abstract][Full Text] [Related]
18. Multiple-stage sampling procedure for covariate-adjusted response-adaptive designs.
Park E; Chang YC
Stat Methods Med Res; 2016 Aug; 25(4):1490-511. PubMed ID: 23723174
[TBL] [Abstract][Full Text] [Related]
19. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
Karrison T; Kocherginsky M
Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
[TBL] [Abstract][Full Text] [Related]
20. Covariate-adjusted adaptive designs for continuous responses in a phase III clinical trial: recommendation for practice.
Biswas A; Huang HH; Huang WT
J Biopharm Stat; 2006; 16(2):227-39. PubMed ID: 16584069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
